Identification of novel fusion partners of ALK, the anaplastic lymphoma kinase, in anaplastic large-cell lymphoma and inflammatory myofibroblastic tumor - Wikidata - wikimedia - TriplyDB

Identification of novel fusion partners of ALK, the anaplastic lymphoma kinase, in anaplastic large-cell lymphoma and inflammatory myofibroblastic tumor

Identification of novel fusion partners of ALK, the anaplastic lymphoma kinase, in anaplastic large-cell lymphoma and inflammatory myofibroblastic tumor

http://www.wikidata.org/entity/Q28214316

about

sameAs

ALK Signaling and Target Therapy in Anaplastic Large Cell Lymphoma Anaplastic lymphoma kinase: signalling in development and disease Pulmonary epithelioid inflammatory myofibroblastic sarcoma with multiple bone metastases: case report and review of literature Inhibitors of the anaplastic lymphoma kinase Breakpoint analysis of transcriptional and genomic profiles uncovers novel gene fusions spanning multiple human cancer types Secreted Mycobacterium tuberculosis Rv3654c and Rv3655c proteins participate in the suppression of macrophage apoptosis Cytology of fine-needle aspiration of inflammatory myofibroblastic tumor.ALK-positive large B-cell lymphomas with cryptic SEC31A-ALK and NPM1-ALK fusions.Molecular strategies for detecting chromosomal translocations in soft tissue tumors (review).An Unusual Case of Systemic Inflammatory Myofibroblastic Tumor with Successful Treatment with ALK-Inhibitor Fusion of EML4 and ALK is associated with development of lung adenocarcinomas lacking EGFR and KRAS mutations and is correlated with ALK expression KLC1-ALK: a novel fusion in lung cancer identified using a formalin-fixed paraffin-embedded tissue only Longitudinal bone marrow evaluations for myelodysplasia in patients with myeloma before and after treatment with lenalidomide.Fusion of the SEC31L1 and ALK genes in an inflammatory myofibroblastic tumor.Prevalence and natural history of ALK positive non-small-cell lung cancer and the clinical impact of targeted therapy with ALK inhibitors Oral inflammatory myofibroblastic tumor: case report and review of literature Molecular genetics of pediatric soft tissue tumors: clinical application.ALK a novel lymphoma-associated tumor antigen for vaccination strategies.Recent progress in the genetics of diabetic microvascular complications.Molecular characterization of inflammatory myofibroblastic tumors with frequent ALK and ROS1 gene fusions and rare novel RET rearrangement Epithelioid inflammatory myofibroblastic sarcoma in abdominal cavity: a case report and review of literature.Characterization of the Tyrosine Kinase-Regulated Proteome in Breast Cancer by Combined use of RNA interference (RNAi) and Stable Isotope Labeling with Amino Acids in Cell Culture (SILAC) Quantitative Proteomics.ALK-immunoreactive neoplasms.A novel TTC40-MSI2 fusion in de novo acute myeloid leukemia with an unbalanced 10;17 translocation.So-called inflammatory myofibroblastic tumour: a proliferative lesion of fibroblastic reticulum cells?Anaplastic lymphoma kinase and its signalling molecules as novel targets in lymphoma therapy.Current management of pediatric soft tissue sarcomas.Fusion tyrosine kinase mediated signalling pathways in the transformation of haematopoietic cells.The cellular functions of clathrin.Diffuse large B-cell lymphoma: a heterogeneous group of non-Hodgkin lymphomas comprising several distinct clinicopathological entities.Genetics of Bladder Malignant Tumors in Childhood Aminoacyl tRNA synthetases and their connections to disease.A novel patient-derived tumorgraft model with TRAF1-ALK anaplastic large-cell lymphoma translocation.Epithelioid inflammatory myofibroblastic sarcoma: a clinicopathological, immunohistochemical and molecular cytogenetic analysis of five additional cases and review of the literature.Gene fusions in soft tissue tumors: Recurrent and overlapping pathogenetic themes Anaplastic lymphoma kinase-positive large B-cell lymphoma: a distinct clinicopathological entity Anaplastic lymphoma kinase: role in cancer pathogenesis and small-molecule inhibitor development for therapy.Intraosseous inflammatory myofibroblastic tumor of the mandible with a novel ATIC-ALK fusion mutation: a case report ALK: a tyrosine kinase target for cancer therapy.Oncogenic mutations of ALK in neuroblastoma.

P2860

Q21129306-1E1CEDBD-F947-4632-A232-09C1B4A06BDA Q24312329-1FDB84A9-0A55-4DF4-9F99-260078767A7D Q26823788-A3837DBD-CA42-4DA8-BA83-BC9307E4D341 Q28267124-FDA4B005-D00D-4F2C-A108-554C137D2D0B Q28486949-BE40917E-DF64-42D1-88C0-A30619984DC0 Q28487022-9FF3DC69-5775-46F8-BAF1-0EA32ACCA498 Q33669118-54864167-9762-4154-B9A6-CEBF5A00E403 Q33707493-E326B3F2-3647-4460-93D5-3C02A09818B2 Q33747747-867AD93D-9645-4AA7-8E64-A24AC65A3F83 Q33865631-10701D77-8E50-49A6-BA26-7F0F36D7CA20 Q34013976-8F7BF3FE-5B3F-4566-BCAC-DAC75DDD9FE5 Q34162787-93AE5A83-3EEF-4940-A1F9-676DC42E9AC0 Q34399099-0B73E5A3-AF5C-4B9F-B27D-71CA1EFCDE4B Q34450749-FB5E3DA5-7C52-4296-9D3F-FA44E075A78E Q34564071-6D4C2F18-9C74-468A-9C4D-B3C5ED196B39 Q34964264-4E261EF9-68F9-40F8-B71D-06A3179335FA Q35183100-4164ABD5-5464-4170-A7BD-EAFB32CB383D Q35614635-F8F16373-40CD-4A8B-8F27-7379477E65B9 Q35691378-7A5C2D91-2F7F-4785-BEC9-97D8D9CC88FA Q35738399-1596CD7B-DBA1-46F6-9B55-16D894A1CD38 Q35741228-A61DAE04-5FF4-475A-88B0-097D7F61F2EA Q36040410-C507D78A-5146-4D7B-BC16-E56A61BFB389 Q36092957-17B212C3-451A-427B-82A5-4EAB0D9277B1 Q36108226-71C26702-4FE1-4584-9B29-3899236EA28F Q36135551-9507A11F-5EEA-452A-BE20-E09010DF63C0 Q36158713-44307832-5DFC-4CC2-819A-0F4AEA008B8C Q36262280-7F39DE03-6825-451E-8022-FA315A3EC71E Q36398134-0DF3EFC0-2AFC-40D4-80F3-EBFA26EEBDA1 Q36478282-DD045CC5-49F9-428B-B2B3-5C9E6CF352B2 Q36622610-62BA024F-7200-430A-905B-3B7A0731AB72 Q36658484-92753D49-E003-4F76-822E-457C29EDF496 Q36837363-BDBA14C3-BCD1-43B7-8151-F78FE9477640 Q36893709-9785456D-B662-4621-8711-06D169FDDEE3 Q37129515-6599FD5A-74A9-47F5-9389-77B4D6FB7421 Q37234080-8794327F-498A-43E9-A14E-538C097C0348 Q37268913-85CEA877-DB77-4259-9246-E36B8F1AE157 Q37411178-10B00EA8-2B50-46F3-BD84-7252A093E38F Q37417034-96D4BD36-95A0-4B7A-969A-E1714480BB45 Q37518624-67DF40DC-F275-49A9-B457-16D3D8F1F537 Q37825940-C80647EB-93E5-4FE3-BDDB-639603BC2FFB

P2860

Identification of novel fusion partners of ALK, the anaplastic lymphoma kinase, in anaplastic large-cell lymphoma and inflammatory myofibroblastic tumor

http://www.wikidata.org/entity/Q28214316

description

2002 թուականի Օգոստոսին հրատարակուած գիտական յօդուած

@hyw

2002 թվականի օգոստոսին հրատարակված գիտական հոդված

@hy

artículu científicu espublizáu en 2002

@ast

im August 2002 veröffentlichter wissenschaftlicher Artikel

@de

scientific article (publication date: August 2002)

@en

vedecký článok (publikovaný 2002-08)

@sk

vědecký článek publikovaný v roce 2002

@cs

wetenschappelijk artikel (gepubliceerd in 2002-08)

@nl

наукова стаття, опублікована в серпні 2002

@uk

مقالة علمية (نشرت في أغسطس 2002)

@ar

name

Identification of novel fusion ...... ammatory myofibroblastic tumor

@ast

Identification of novel fusion ...... ammatory myofibroblastic tumor

@en

Identification of novel fusion ...... ammatory myofibroblastic tumor

@nl

type

label

Identification of novel fusion ...... ammatory myofibroblastic tumor

@ast

Identification of novel fusion ...... ammatory myofibroblastic tumor

@en

Identification of novel fusion ...... ammatory myofibroblastic tumor

@nl

prefLabel

Identification of novel fusion ...... ammatory myofibroblastic tumor

@ast

Identification of novel fusion ...... ammatory myofibroblastic tumor

@en

Identification of novel fusion ...... ammatory myofibroblastic tumor

@nl

P1433

Q28214316-E5CA89A8-3167-40B8-866E-CF99C657C2C1

P1476

Q28214316-76E2938B-A8EA-4473-B68C-981BFB1732C8

P2093

Q28214316-5194EAF9-98A0-4E7A-8140-728C5B64A144

Q28214316-5E55FBC2-9DC2-427F-9DB8-8FA64425C3DF

Q28214316-60BF313B-F666-4136-A21B-F7BD3CE0C8A9

Q28214316-6E50B6E8-E79A-4B2E-ABCE-2F7EA635658E

Q28214316-929E38E3-79CF-49D4-B62A-0779280E9CDE

Q28214316-A754EC07-D192-4F17-BA75-627BC395C1A4

P2860

Q28214316-0C9618EB-A432-4819-9277-09DEE8DD53CD

Q28214316-1BDC8250-EFBD-4271-8589-2CD12B836F4F

Q28214316-4C5A784A-101C-483E-AD16-BD269407B2D3

Q28214316-523592AF-B1A2-478E-BCEF-08C24308B1E0

Q28214316-675D63D0-FDD7-46E6-B452-AEE7F66A37AA

Q28214316-7275E4A8-5A44-47D9-812F-D99A847FD1EF

Q28214316-74777AB9-62E0-48B6-A72C-0ED0B390B9D3

Q28214316-7929757E-4DCE-45E7-97C5-56F4840BF5C9

Q28214316-9A7C8410-7DD9-4356-96E4-7EE35F0AD141

Q28214316-9D018185-7ABA-423A-B718-0AEDEA2D37B8

P304

Q28214316-9FCA8359-73BD-425C-A187-5BA3605FAFCA

P31

Q28214316-8ACDEAD5-19C3-4106-B287-16D68C3E79ED

P3181

Q28214316-B9126EAF-7D67-432F-ACD4-8DAE070F0B57

P356

Q28214316-AA74F91B-056B-4992-8CF9-F5F839893544

P407

Q28214316-26BDBD33-AB9B-4D0A-AB65-8C73B7C9694C

P433

Q28214316-4588A421-185A-4906-9159-1EB05C138474

P478

Q28214316-6481FF65-280E-46BF-BA94-4776464336BB

P50

Q28214316-0195D141-2649-4BFB-804A-DBB55CBD11CC

Q28214316-56A93653-05B7-4416-B33B-2320C62E69FD

Q28214316-DE4117BF-F664-4962-996A-1FA20D61C6A3

Q28214316-FE1CBBC5-BCEC-4062-B27F-2B4993C67129

P577

Q28214316-BDC1B558-3C1F-4D0E-B97F-A7B746FDA993

P698

Q28214316-2E018CA8-B9E8-4282-97FE-F7154DDA6730

P921

Q28214316-DB544513-ED80-4DDF-B8D9-77A904842098

P3181

P356

P1433

Genes, Chromosomes and Cancer

P1476

Identification of novel fusion ...... ammatory myofibroblastic tumor

@en

P2093

Anne Hagemeijer

http://www.w3.org/2001/XMLSchema#string

Brigitte Maes

http://www.w3.org/2001/XMLSchema#string

Florence Pedeutour

http://www.w3.org/2001/XMLSchema#string

Nicole Mentens

http://www.w3.org/2001/XMLSchema#string

Patrick Pauwels

http://www.w3.org/2001/XMLSchema#string

Peter Marynen

http://www.w3.org/2001/XMLSchema#string

P2860

Nucleotide and deduced amino acid sequence of human cysteinyl-tRNA synthetase

Role of the nucleophosmin (NPM) portion of the non-Hodgkin's lymphoma-associated NPM-anaplastic lymphoma kinase fusion protein in oncogenesis

Human clathrin heavy chain (CLTC): partial molecular cloning, expression, and mapping of the gene to human chromosome 17q11-qter

ALK, the chromosome 2 gene locus altered by the t(2;5) in non-Hodgkin's lymphoma, encodes a novel neural receptor tyrosine kinase that is highly related to leukocyte tyrosine kinase (LTK)

TPM3-ALK and TPM4-ALK oncogenes in inflammatory myofibroblastic tumors

Clathrin self-assembly is mediated by a tandemly repeated superhelix

Cysteinyl-tRNA synthetase from Saccharomyces cerevisiae. Purification, characterization and assignment to the genomic sequence YNL247w.

Identification of anaplastic lymphoma kinase as a receptor for the growth factor pleiotrophin

Fusion of a kinase gene, ALK, to a nucleolar protein gene, NPM, in non-Hodgkin's lymphoma

A 2.5-Mb transcript map of a tumor-suppressing subchromosomal transferable fragment from 11p15.5, and isolation and sequence analysis of three novel genes

P304

354-62

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P3181

2562585

http://www.w3.org/2001/XMLSchema#string

P356

10.1002/GCC.10033

http://www.w3.org/2001/XMLSchema#string

P407

P433

4

http://www.w3.org/2001/XMLSchema#string

P478

34

http://www.w3.org/2001/XMLSchema#string

P50

Christiane De Wolf-Peeters

Iwona Wlodarska

P577

2002-08-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

12112524

http://www.w3.org/2001/XMLSchema#string

P921